Interleukin 1β induces functional prostaglandin e synthase in cultured human umbilical vein endothelial cells

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 I, 2002, Pages 643-654

  Uracz, Wojcieh ^a   Uracz, D ^a   Olszanecki, R ^a   Gryglewski, R J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cyclooxygenase; Functional gene expression; Interleukin 1 ; Prostaglandin E2; Prostaglandin E2 synthase

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DACTINOMYCIN; DEXAMETHASONE; DNA; INDOMETACIN; MESSENGER RNA; PARACETAMOL; PROSTAGLANDIN E; PROSTAGLANDIN SYNTHASE; RECOMBINANT INTERLEUKIN 1BETA; RNA; INTERLEUKIN 1; ISOENZYME; ISOMERASE; MEMBRANE PROTEIN; PROSTAGLANDIN E SYNTHASE; PTGS2 PROTEIN, HUMAN;

ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PROSTAGLANDIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; ARTICLE; CELL CULTURE; ENZYMOLOGY; GENETICS; METABOLISM; OSMOLARITY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-1; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MEMBRANE PROTEINS; OSMOLAR CONCENTRATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS;

EID: 0037530141     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991; 5:2304-2312.
2. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992; 89:7384-7388.
3. Hla T. Molecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcript. Prostaglandins 1996; 51:81-85.
4. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266:12866-12872.
5. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991; 266:23261-23267.
6. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc Natl Acad Sci USA 1991; 88:2692-2696.
7. Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 1976; 12:685-713.
8. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 1975; 72:2994-2998.
9. Chan JA, Nagasawa M, Takeguchi C, Sih CJ. On agents favoring prostaglandin f formation during biosynthesis. Biochemistry 1975; 14:2987-2991.
10. Nugteren DH, Christ-Hazelhof E. Chemical and enzymic conversions of the prostaglandin endoperoxide PGH2. Adv Prostaglandin Thromboxane Res 1980; 6:129-137.
11. Soler M, Camacho M, Escudero JR, Iniguez MA, Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res 2000; 87:504-507.
12. Wubert J, Reder E, Kaser A, Weber PC, Lorenz RL. Simultaneous solid phase extraction, derivatization, and gas chromatographic mass spectrometric quantification of thromboxane and prostacyclin metabolites, prostaglandins, and isoprostanes in urine. Anal Chem 1997; 69:2143-2146.
13. Gerritsen ME, Printz MP. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ Res 1981; 49:1152-1163.
14. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999; 96:7220-7225.
15. Han R, Smith TJ. Cytoplasmic prostaglandin E2 synthase is dominantly expressed in cultured KAT-50 thyrocytes, cells which express constitutive prostaglandin endoperoxide H synthase-2: Basis for low prostaglandin E2 production. J Biol Chem 2002.
16. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000; 275:32783-32792.
17. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000; 275:32775-32782.
18. Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson PJ, DeLellis RA et al. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 2001; 7:3971-3976.
19. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 2002; 291:884-889.
20. Haider A, Olszanecki R, Gryglewski R, Schwartzman ML, Lianos E, Kappas A et al. Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther 2002; 300:188-194.
21. Tamura M, Sebastian S, Gurates B, Yang S, Fang Z, Bulun SE. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab 2002; 87:3504-3507.
22. Tamura M, Sebastian S, Yang S, Gurates B, Fang Z, Bulun SE. Interleukin-1 beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: An effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab 2002; 87:3263-3273.
23. Gryglewski RJ, Uracz W, Chlopicki S, Marcinkiewicz E. Bradykinin as a major endogenous regulator of endothelial function. Pediatr Pathol Mol Med 2002; 21:279-290.
24. Uracz W, Gȩbska A, Ziemianin B, Chłopicki S, Gryglewski RJ. Role of nitric oxide synthase types II and III in early protection against endotoxin-induced lung. Experimental and Clinical Cardiology 1998; 3:78-86.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
26. Ingerman-Wojenski CM, Silver MJ, Mueller SN, Levine EM. Prostacyclin synthesis by endothelial cells from human umbilical veins: Effect of cumulative population doublings. Prostaglandins 1988; 36:127-137.
27. Neubert K, Haberland A, Kruse I, Wirth M, Schimke I. The ratio of formation of prostacyclin/thromboxane A2 in HUVEC decreased in each subsequent passage. Prostaglandins 1997; 54:447-462.
28. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91:281-291.
29. Brock TG, McNish RW, Peters-Golden M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem 1999; 274:11660-11666.
30. Matsumoto H, Naraba H, Murakami M, Kudo I, Yamaki K, Ueno A et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem Biophys Res Commun 1997; 230:110-114.
31. Naraba H, Murakami M, Matsumoto H, Shimbara S, Ueno A, Kudo I et al. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. Immunol 1998; 160:2974-2982.
32. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: Regulation and relevance in inflammation. Biochem Pharmacol 1995; 50:1535-1542.
33. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1 beta. Biochem Biophys Res Commun 1997; 237:28-32.
34. Newton R, Seybold J, Kuitert LM, Bergmann M, Barnes PJ. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 1998; 273:32312-32321.
35. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Lean A, Nemer M et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993; 12:145-156.
36. Konig H, Ponta H, Rahmsdorf HJ, Herrlich P. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992; 11:2241-2246.
37. Newton R, Hart LA, Stevens DA, Bergmann M, Donnelly LE, Adcock IM et al. Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. Eur J Biochem 1998; 254:81-89.
38. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91:752-756.
39. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS, Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283-286.
40. Vane RJ. The fight against rheumatism: From willow bark to COX-1 sparing drugs. J Physiol Pharmacol 2000; 51(4 Pt 1):578-586.
41. Botting R. Paracetamol-inhibitable COX-2. J Physiol Pharmacol 2000; 51(4 Pt 1):609-618.
42. Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci U S A 1999; 96:3275-3280.
43. Botting RM. Mechanism of action of acetaminophen: Is there a cyclooxygenase 3? Clin Infect Dis 2000; 31 Suppl 5:S202-S210.
44. Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000; 355(9204):646-648.
45. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: Role of mitochondrial oxidant stress. Toxicol Sci 2001; 62:212-220.
46. Knight TR, Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: Mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002; 181:133-141.
47. Robak J, Wieckowski A, Gryglewski R. The effect of 4-acetamidophenol on prostaglandin synthetase activity in bovine and rain seminal vesicle microsomes. Biochem Pharmacol 1978; 27:393-396.
48. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268:9049-9054.
49. Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: Selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001; 167: 2831-2838.
50. Ogasawara A, Arakawa T, Kaneda T, Takuma T, Sato T, Kaneko H et al. Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP beta, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem 2001; 276:7048-7054.
51. Wadhwa S, Godwin SL, Peterson DR, Epstein MA, Raisz LG, Pilbeam CC. Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway. J Bone Miner Res 2002; 17:266-274.
52. Uracz D, Uracz W, Gryglewski RJ. Bradykinin as a strong inducer of COX-2 mRNA and a weak inducer of NOS-2 mRNA in cultured endothelial cells from human umbilical vein. In: Gryglewski RJ, Minuz P, editors. Nitric Oxide - Basic Research and Clinical Application. 10S Press, 2001: 207-209.